Bergen, Norway, 9 December 2020 - Extraordinary General Meeting in BerGenBio
ASA<br />
is being held virtually today 9 December 2020 at 16:00 hours (CET).<br />
<br />
Information on how to join the meeting:<br />
<br />
Webcast link: https://web.lumiagm.com/?fromUrl=127403163<br />
<br />
Meeting ID: 127-403-163<br />
<br />
Please note you must be logged in online before the meeting starts to be able
to<br />
vote on issues on the agenda. You will then be required to enter your ID: a)<br
/>
reference number from VPS and b) PIN code from VPS<br />
<br />
Guide for online participation can be found at www.bergenbio.com under
Investors<br />
/ General meetings<br />
<br />
-Ends-<br />
<br />
For further information, please contact:<br />
<br />
Richard Godfrey CEO, BerGenBio ASA<br />
+47 917 86 304<br />
<br />
Rune Skeie, CFO, BerGenBio ASA<br />
rune.skeie@bergenbio.com<br />
+47 917 86 513<br />
<br />
Forward looking statements<br />
<br />
This announcement may contain forward-looking statements, which as such are
not<br />
historical facts, but are based upon various assumptions, many of which are<br
/>
based, in turn, upon further assumptions. These assumptions are inherently<br />
subject to significant known and unknown risks, uncertainties and other<br />
important factors. Such risks, uncertainties, contingencies and other
important<br />
factors could cause actual events to differ materially from the expectations<br
/>
expressed or implied in this announcement by such forward-looking statements.<br
/>
<br />
This information is subject to the disclosure requirements pursuant to section
5<br />
-12 of the Norwegian Securities Trading Act.